Deferred Tax Assets, Valuation Allowance of Forte Biosciences, Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Forte Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Forte Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $24,501,000, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Forte Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $24,501,000 +$5,899,000 +32% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $18,602,000 +$6,387,000 +52% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $12,215,000 +$2,629,000 +27% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q4 2021 $9,586,000 +$3,807,000 +66% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $5,779,000 +$4,390,000 +316% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $1,389,000 -$3,718,000 -73% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q4 2018 $5,107,000 +$2,773,000 +119% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $2,334,000 +$386,000 +20% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $1,948,000 31 Dec 2016 10-K 09 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.